Neuroscience approach in Stem cell therapy among patients with Spinal Cord Injury
International Clinical Neuroscience Journal,
Vol. 2 No. 1 (2015),
3 March 2015
,
Page 1-7
https://doi.org/10.22037/icnj.v2i1.7773
Abstract
The first necessary step in researches to treat spinal cord injuries (SCI) is to understand complexities related to the neurophysiology and neurobiology changes of human SCI with stem cell therapy(SCT). The aim of this study is to identify these changes. The level of injuries is important in treatment and determination of this injury (whether it is complete, incomplete, or discomplete) is valuable too. Loss of all neurological functions affected by this injury and physiological or anatomical continuity of central nervous system tracts occur across this lesion. Obviously, a result that is achieved is that the maximum number of tracts can remain, be maintained, and increase in the acute phase of illness. Stimulating the axonal regeneration by neutralizing inhibitory factors, adding positive tropisms, and creating a permissive environment is suitable. Better results that had been obtained are achieved by filling gaps with peripheral nerve grafts or transplanting Schwann cells, and fibroblasts that genetic engineering has been done on them. Ability of poly potential cells to differentiate and create neural tissues is remarkable. The relatively good success in obtaining the proper repair for axons has been reported. However, this issue also should be considered that human spinal cord injuries have significant differences with spinal cord injuries in laboratory animals. In order to be successful in doing this research, the changes of human SCI must also be considered and the use of stem cells in treating human SCI must be performed due to these changes.- Neuroscience
- Stem cell therapy
- Spinal Cord Injury
How to Cite
References
Kakulas BA. Problems and solutions in the rehabilitation of patients with progressive muscular dystrophy. Scand J Rehabil Med Suppl. 1999;39:23-37.
Dimitrijevic MR.Residual motor functions in spinal cord injury. In: Waxman SG. Functional Recovery in Neurological Disease. Raven Press: New York. 1988; 139–155.
Kaelan C. Neuropathology and clinical neurobiology of human spinal cord injury (SCI): quantitation of tissue elements in human SCI and the comparison of experimental animal SCI and human SCI. PhD Thesis, University of Western Australia; 1993.
Wolman L. The disturbance of circulation in traumatic paraplegia in acute and late stages: a pathological study. Parraplegia. 1965 Mar;2:213-26.
Cheng H, Cao YH, Olson L. Spinal-cord repair in adult paraplegic rats: partial restoration of hind-limb function. Science. 1996 Jul 26;273(5274):510-3.
Kakulas BA, Lorimer RL, Gubbay AD. White matter changes in human spinal cord injury. In: Stalberg E, Sharma HR, Olsson Y (eds). Spinal Cord Monitoring: Basic Principles, Regeneration, Pathophysiology and Clinical Aspects. Springer-Verlag Publishers: Wein, New York. 1998: 395–407.
Tator C. Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol. 1995 Oct;5(4):407-13.
Tator CH. Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery. 1998 Apr;42(4):696-707; discussion 707-8.
Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322(20):1405–1411
Grillner S. Neural networks for vertebrate locomotion. The motions animals use to swim, run and fly are controlled by specialized neural networks. For a jawless fish known as the lamprey, the circuitry has been worked out. Sci Am. 1996; 274: 48–53.
Stokes BT, Jakeman LB. Experimental modeling of human spinal cord injury: a model that crosses the species barrier and mimics the spectrum of human cytopathology. Spinal Cord. 2002 Mar;40(3):101-9.
Sharifian M, Anvati pour N, Zali AR. Urinary tract complications in patients with spinal dysraphism. Pak J Med Sci. 2008; 24(5): 729-734.
Brook GA, Houweling DA, Gieling RG, Hermanns T, Joosten EA, Bar DP, et al. Attempted endogenous tissue repair following experimental spinal cord injury in the rat: involvement of cell adhesion molecules L1 and NCAM? Eur J Neurosci. 2000; 12(9): 3224-3238.
Teng YD, Lavik EB, Qu X et al. Functional recovery following spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3024-9.
Levi A D, Guenard V, Aebischer P, Bunge R P. The functional characteristics of Schwann cells cultured from human peripheral nerve after transplantation into a gap within the rat sciatic nerve. J Neurosci. 1994 Mar;14(3 Pt 1):1309-19.
Fawcett JW. Spinal cord repair: from experimental models to human application. Spinal Cord. 1998 Dec;36(12):811-7.
Diener PS, Bregman BS. Fetal spinal cord transplants support growth of supraspinal and segmental projections after cervical spinal cord hemisection in the neonatal rat. J Neurosci. 1998, 18(2): 779-793
Geisler FH. Clinical trials of pharmacotherapy for spinal cord injury. Ann N Y Acad Sci. 1998 Jun 19;845:374-81.
Aguayo AJ, Bray GM, Carter DA, Villegas-Perez MP, Vidal-Sanz M. Regrowth and connectivity of injured central nervous system axons in adult rodents. Acta Neurobiol Exp (Wars). 1990;50(4-5):381-9.
Raisman G. A promising therapeutic approach to spinal cord repair (editorial). J R Soc Med. 2003 Jun;96(6):259-61.
Ramon CA, Plant GW, Avila J, Bunge MB. Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci. 1998 May 15;18(10):3803-15.
Rapalino O, Lazarov-Spiegler O, Agranov E, Velan GJ, Yoles E, Fraidakis M, et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med. 1998 Jul;4(7):814-21.
Hess DC, Hill WD, Carroll JE, Borlongan CV. Do bone marrow cells generate neurons? Arch Neurol. 2004 Apr;61(4):483-5.
Schmitt AB, Breuer S, Polat L, Pech K, Kakulas B, Love S, et al. Retrograde reactions of Clarke's nucleus neurons after human spinal cord injury. Ann Neurol. 2003 Oct;54(4):534-9.
Barker RA, Jain M, Armstrong RJE, Caldwell MA. Editorial: stem cells and neurological disease. J Neurol Neurosurg Psychiatry. 2003 May;74(5):553-7.
Tai Y-T, Svendsen CN. Stem cells as a potential treatment of neurological disorders. Curr Opin Pharmacol. 2004 Feb;4(1):98-104.
Pearse DD, Pereira FC, Marcillo AE, Bates ML, Berrocal YA, Filbin MT, et al. cAMP and Schwann cells promote axonal growth and function recovery after spinal cord injury. Nat Med. 2004 Jun;10(6):610-6.
Moreno-Flores T, Diaz-Nido J, Wandosell F, Avila J. Olfactory ensheathing glia: drivers of axonal regeneration in the central nervous system? J Biomed Biotechnol. 2002; 2(1): 37–43.
Plant GW, Christensen CL, Oudega M, Bunge MB. Delayed transplantation of olfactory ensheathing glia promotes sparing/regeneration of supraspinal axons in the contused adult rat spinal cord. J Neurotrauma. 2003 Jan;20(1):1-16.
Buss A, Brook GA, Kakulas B, Martin D, Franzen R, Schoenen J, et al. Gradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord. Brain. 2004 Jan;127(Pt 1):34-44.
Wagers AJ, Christensen JL, Weissman IL. Cell fate determination from stem cells. Gene Therapy. 2002 May;9(10):606-12.
Guttman L. Spinal Cord Injuries. Comprehensive Management and Research, 2nd ed. Blackwell Scientific Publications: London; 1976.
Li Y, Field PM, Raisman G. Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J Neurosci 1998 Dec 15;18(24):10514-24.
Rosenfeld JV, Gillett GR. Ethics, stem cells and spinal cord repair. Med J Aust. 2004 Jun 21;180(12):637-9.
Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med. 2001 Mar 8;344(10):710-9.
Harvey AR, Plant GW. Schwann cells and fetal tectal tissue cografted to the midbrain of newborn rats: fate of Schwann cells and their influence on host retinal innervation of grafts. Exp Neurol. 1995 Aug;134(2):179-91.
Jin Y, Fischer I, Tessler A, Houle JD. Transplants of fibroblasts genetically modified to express BDNF promote axonal regeneration from supraspinal neurons following chronic spinal cord injury. Exp Neurol. 2002 Sep;177(1):265-75.
Wu S, Suzuki Y, Kitada M, Kitaura M, Kataoka K, Takahashi J, et al. Migration, integration, and differentiation of hippocampus-derived neurosphere cells after transplantation into injured rat spinal cord. Neurosci Lett. 2001 Oct 26;312(3):173-6.
Rosario CM, Yandava BD, Kosaras B, Zurakowski D, Sidman RL, Snyder EY. Differentiation of engrafted multipotent neural progenitors towards replacement of missing granules neurons in meander tail cerebellum may help determines the locus of mutant gene action. Development. 1997 Nov;124(21):4213-24.
Herman R, He J, D'Luzansky S, Willis W, Dilli S. Spinal cord stimulation facilitates functional walking in achronic, incomplete spinal cord injured. Spinal Cord. 2002 Feb;40(2):65-8.
Agrawal S, Schaffer DV. In situ stem cell therapy: novel targets, familiar challenges. Trends Biotechnol. 2005 Feb;23(2):78-83.
Lai K, Kaspar BK, Gage FH, Schaffer DV. Sonic Hedgehog regulates adult neural progenitor proliferation in vitro and vivo. Nat Neurosci. 2003 Jan;6(1):21-7.
Zarghi A, Zali A, Ashrafi F, Moazzezi S, Lotfi M. Promotion of Neuro-cognitive domains with working memory computerized test (WMCT) among healthy adult. Int J Eng Tech Res. 2014; 2: 333-337.
Zarghi A. Functional neurosurgery and neurocognitive rehabilitation. Int clin neurosci J. 2014;1(2):43-47.
Zarghi A, Zali A, Ashrafi F, Moazezi S. Neuroscience and Neuro-cognitive Rehabilitation. Basic Res J Med Clin Sci. 2013; 2 (8): 83-87.
Zarghi A, Zali A, Ashrafi F, Moazezi S. Neuro-cognitive rehabilitation among patients with spinal cord injury treated with stem cell. Neurosci Discov. 2014;2 (1):2-8.
- Abstract Viewed: 250 times
- PDF Downloaded: 203 times